The Kaplan–Meier survival analysis showed that high level of SLFN5 is significantly associated with weak overall survival in ovarian cancer (Fig. 3D, P = 0.0076), which is consistent with the result from the TCGA ovarian cancer cohort. Here, SLFN5 is linked to ovarian cancer.